Abaxis to Report Third Quarter Fiscal 2010 Financial Results Thursday, January 28, 2010
28 1월 2010 - 9:45PM
PR Newswire (US)
UNION CITY, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Abaxis, Inc.
(NASDAQ:ABAX), a medical products company manufacturing
point-of-care blood analysis systems, has scheduled a conference
call to discuss its financial results for the third quarter of
fiscal year 2010, ended December 31, 2009. The call will be at 4:15
p.m. ET on Thursday, January 28, 2010. Participants can dial (800)
860-2442 or (412) 858-4600 to access the conference call, or can
listen via a live Internet web cast, which is available in the
Investor Relations section of the company's website at
http://www.abaxis.com/. A replay of the call is available by
visiting http://www.abaxis.com/ for the next 30 days or by calling
(877) 344-7529 or (412) 317-0088, confirmation code 437292, through
February 1, 2010. About Abaxis Abaxis develops, manufactures and
markets portable blood analysis systems for use in any veterinary
or human patient-care setting to provide clinicians with rapid
blood constituent measurements. The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The system can
be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples. The system provides
test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. Contact:
Clint Severson Lytham Partners, LLC Chief Executive Officer Joe
Dorame, Joe Diaz & Robert Blum Abaxis, Inc. 602-889-9700
510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT: Clint Severson,
Chief Executive Officer of Abaxis, Inc., +1-510-675-6500; or Joe
Dorame, Joe Diaz & Robert Blum of Lytham Partners, LLC,
+1-602-889-9700, for Abaxis, Inc. Web Site: http://www.abaxis.com/
Copyright